(Q40307342)

19 September 2017

title

DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells (English)

1 reference

chronic lymphocytic leukemia

19 September 2017

0 references

1 reference

R Horie

1

1 reference

19 September 2017

M Watanabe

2

1 reference

19 September 2017

T Okamura

3

1 reference

19 September 2017

M Taira

4

1 reference

19 September 2017

M Shoda

5

1 reference

19 September 2017

T Motoji

6

1 reference

19 September 2017

A Utsunomiya

7

1 reference

19 September 2017

T Watanabe

8

1 reference

19 September 2017

M Higashihara

9

1 reference

19 September 2017

K Umezawa

10

1 reference

19 September 2017

publication date

1 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

20

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

800-806

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404167

19 September 2017

exact match

0 references

cites work

The biology of signal transduction inhibition: basic science to novel therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

Imatinib: the first 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

Control of apoptosis by Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

Treatment of human chronic lymphocytic leukemia cells with the proteasome inhibitor bortezomib promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

inferred from DOI database lookup

7 January 2021

based on heuristic

Synthesis of NF-kappaB activation inhibitors derived from epoxyquinomicin C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

inferred from DOI database lookup

7 January 2021

based on heuristic

Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404167

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2404167

1 reference

Dimensions Publication ID

19 September 2017

1008798166

0 references

1 reference